{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:02:22Z","timestamp":1794646942764,"version":"4.9.1"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374386"],"award-info":[{"award-number":["82374386"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.metabol.2026.156621","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:12:12Z","timestamp":1776172332000},"page":"156621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["6-phosphofructo-2-kinase\/fructose-2,6-biphosphatase 3: A potential target in the development of diabetes and its complications"],"prefix":"10.1016","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8712-6890","authenticated-orcid":false,"given":"Minmin","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9284-7406","authenticated-orcid":false,"given":"Xiaofei","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.metabol.2026.156621_bb0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/pharmrev.123.001015","article-title":"The role of G protein-coupled receptors and receptor kinases in pancreatic \u03b2-cell function and diabetes","volume":"76","author":"Varney","year":"2024","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.metabol.2026.156621_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jare.2023.10.008","article-title":"\u03b2-cell neogenesis: A rising star to rescue diabetes mellitus","volume":"62","author":"Niu","year":"2024","journal-title":"J Adv Res"},{"issue":"2","key":"10.1016\/j.metabol.2026.156621_bb0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1210\/endrev\/bnad030","article-title":"Protective factors and the pathogenesis of complications in diabetes","volume":"45","author":"Yu","year":"2024","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.metabol.2026.156621_bb0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/db16-0806","article-title":"Differentiation of diabetes by pathophysiology, natural history, and prognosis","volume":"66","author":"Skyler","year":"2017","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.metabol.2026.156621_bb0030","article-title":"Endothelial-to-mesenchymal transition: An underappreciated mediator of diabetic complications","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0035","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12933-020-01159-5","article-title":"Global trend of diabetes mortality attributed to vascular complications, 2000-2016","volume":"19","author":"Ling","year":"2020","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"10.1016\/j.metabol.2026.156621_bb0040","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00075197-200109000-00012","article-title":"6-Phosphofructo-2-kinase\/fructose-2,6-bisphosphatase: suiting structure to need, in a family of tissue-specific enzymes","volume":"4","author":"El-Maghrabi","year":"2001","journal-title":"Curr Opin Clin Nutr"},{"issue":"3\u20134","key":"10.1016\/j.metabol.2026.156621_bb0045","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000015181","article-title":"Molecular cloning, expression, and chromosomal localization of a ubiquitously expressed human 6-phosphofructo-2-kinase\/ fructose-2, 6-bisphosphatase gene (PFKFB3)","volume":"83","author":"Manzano","year":"1998","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/j.metabol.2026.156621_bb0050","article-title":"Roles of PFKFB3 in cancer","volume":"2","author":"Shi","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.metabol.2026.156621_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217573","article-title":"SUMOylated hnRNPM suppresses PFKFB3 phosphorylation to regulate glycolysis and tumorigenesis","volume":"616","author":"Zhong","year":"2025","journal-title":"Cancer Lett"},{"issue":"6","key":"10.1016\/j.metabol.2026.156621_bb0060","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.cmet.2020.05.004","article-title":"Endothelial lactate controls muscle regeneration from ischemia by inducing M2-like macrophage polarization","volume":"31","author":"Zhang","year":"2020","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.metabol.2026.156621_bb0065","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s11427-024-2823-2","article-title":"SIRT3 deficiency reduces PFKFB3-driven T-cell glycolysis and promotes arthritic inflammation","volume":"68","author":"Wang","year":"2025","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.metabol.2026.156621_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104292","article-title":"Ablation of endothelial Pfkfb3 protects mice from acute lung injury in LPS-induced endotoxemia","volume":"146","author":"Wang","year":"2019","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cmet.2013.11.008","article-title":"Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis","volume":"19","author":"Schoors","year":"2014","journal-title":"Cell Metab"},{"issue":"7","key":"10.1016\/j.metabol.2026.156621_bb0080","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/s42255-024-01049-0","article-title":"Weak neuronal glycolysis sustains cognition and organismal fitness","volume":"6","author":"Jimenez-Blasco","year":"2024","journal-title":"Nat Metab"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0085","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41392-022-01097-6","article-title":"Suppression of PFKFB3-driven glycolysis restrains endothelial-to-mesenchymal transition and fibrotic response","volume":"7","author":"Zeng","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13578-024-01205-9","article-title":"PFKFB3 in neovascular eye disease: unraveling mechanisms and exploring therapeutic strategies","volume":"14","author":"Liu","year":"2024","journal-title":"Cell Biosci"},{"issue":"6","key":"10.1016\/j.metabol.2026.156621_bb0095","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2024.5429","article-title":"Advances in the understanding of the role and mechanism of action of PFKFB3-mediated glycolysis in liver fibrosis (review)","volume":"54","author":"Liu","year":"2024","journal-title":"Int J Mol Med"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00125-019-05030-5","article-title":"Activation of the HIF1\u03b1\/PFKFB3 stress response pathway in beta cells in type 1 diabetes","volume":"63","author":"Nomoto","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2026.156621_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1552700","article-title":"Metabolic adaptation to acute metabolic stress via PFKFB3 upregulation in rodent beta cells","volume":"16","author":"Chiba","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2026.156621_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.669456","article-title":"Glycolysis inhibition induces functional and metabolic exhaustion of CD4(+) T cells in type 1 diabetes","volume":"12","author":"Martins","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0115","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/s41467-019-10444-1","article-title":"IAPP toxicity activates HIF1\u03b1\/PFKFB3 signaling delaying \u03b2-cell loss at the expense of \u03b2-cell function","volume":"10","author":"Montemurro","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0120","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s42003-022-03209-y","article-title":"\u03b2-Cell-specific deletion of PFKFB3 restores cell fitness competition and physiological replication under diabetogenic stress","volume":"5","author":"Min","year":"2022","journal-title":"Commun Biol"},{"issue":"12","key":"10.1016\/j.metabol.2026.156621_bb0125","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202402743","article-title":"Dysfunctional \u03b2-cell longevity in diabetes relies on energy conservation and positive epistasis","volume":"7","author":"Raval","year":"2024","journal-title":"Life Sci Alliance"},{"issue":"16","key":"10.1016\/j.metabol.2026.156621_bb0130","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1111\/j.1742-4658.2009.07161.x","article-title":"Pfkfb3 is transcriptionally upregulated in diabetic mouse liver through proliferative signals","volume":"276","author":"Duran","year":"2009","journal-title":"FEBS J"},{"issue":"10","key":"10.1016\/j.metabol.2026.156621_bb0135","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1161\/HYPERTENSIONAHA.123.21341","article-title":"Type 1 diabetes impairs endothelium-dependent relaxation via increasing endothelial cell glycolysis through advanced glycation end products, PFKFB3, and Nox1-mediated mechanisms","volume":"80","author":"Atawia","year":"2023","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.metabol.2026.156621_bb0140","article-title":"PFKFB3 connects glycolytic metabolism with endothelial dysfunction in human and rodent obesity","volume":"14","author":"Batori","year":"2025","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"10.1016\/j.metabol.2026.156621_bb0145","doi-asserted-by":"crossref","first-page":"E312","DOI":"10.1152\/ajpendo.00569.2018","article-title":"Pyridostigmine regulates glucose metabolism and mitochondrial homeostasis to reduce myocardial vulnerability to injury in diabetic mice","volume":"317","author":"Yang","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0150","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-024-05257-5","article-title":"Cardiac-specific PFKFB3 overexpression prevents diabetic cardiomyopathy via enhancing OPA1 stabilization mediated by K6-linked ubiquitination","volume":"81","author":"Luo","year":"2024","journal-title":"Cell Mol Life Sci"},{"issue":"26","key":"10.1016\/j.metabol.2026.156621_bb0155","doi-asserted-by":"crossref","first-page":"13634","DOI":"10.1074\/jbc.M116.722496","article-title":"Type 2 diabetes dysregulates glucose metabolism in cardiac progenitor cells","volume":"291","author":"Salabei","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2026.156621_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116920","article-title":"Increased SUMO-activating enzyme subunit 1 promotes glycolysis and fibrotic phenotype of diabetic nephropathy","volume":"237","author":"Wusiman","year":"2025","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.metabol.2026.156621_bb0165","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3892\/mmr.2021.12405","article-title":"Silencing of PFKFB3 protects podocytes against high glucose-induced injury by inducing autophagy","volume":"24","author":"Zhu","year":"2021","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0170","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/13880209.2025.2607563","article-title":"Cyanoglycosides isolated from Moringa oleifera seeds inhibited PFKFB3\/TGF-\u03b21\/smads pathway to alleviate diabetic nephropathy through driving metabolic reprogramming","volume":"64","author":"Ge","year":"2026","journal-title":"Pharm Biol"},{"issue":"5","key":"10.1016\/j.metabol.2026.156621_bb0175","first-page":"C1354","article-title":"Glycolytic enzyme PFKFB3 regulates sphingosine 1-phosphate receptor 1 in proangiogenic glomerular endothelial cells under diabetic condition","volume":"325","author":"Yu","year":"2023","journal-title":"Am J Phys Cell Phys"},{"issue":"4","key":"10.1016\/j.metabol.2026.156621_bb0180","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41419-022-04803-y","article-title":"IGFBP5 promotes diabetic kidney disease progression by enhancing PFKFB3-mediated endothelial glycolysis","volume":"13","author":"Song","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.metabol.2026.156621_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102589","article-title":"Enhancement of glycolysis-dependent DNA repair regulated by FOXO1 knockdown via PFKFB3 attenuates hyperglycemia-induced endothelial oxidative stress injury","volume":"59","author":"Sun","year":"2023","journal-title":"Redox Biol"},{"key":"10.1016\/j.metabol.2026.156621_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2026.156553","article-title":"PFKFB3 nuclear translocation improves diabetic retinopathy by attenuating endothelial cell senescence through inhibition of USP7-p53 axis","volume":"178","author":"Liu","year":"2026","journal-title":"Metab Clin Exp"},{"issue":"11","key":"10.1016\/j.metabol.2026.156621_bb0195","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.2337\/db23-1015","article-title":"M\u00fcller cells harboring Exosomal lncRNA OGRU modulate microglia polarization in diabetic retinopathy by serving as miRNA sponges","volume":"73","author":"Fu","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2026.156621_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.900640","article-title":"Investigation of retinal metabolic function in type 1 diabetic Akita mice","volume":"9","author":"Shosha","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0205","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12967-024-05046-5","article-title":"WNT-inhibitory factor 1-mediated glycolysis protects photoreceptor cells in diabetic retinopathy","volume":"22","author":"Chen","year":"2024","journal-title":"J Transl Med"},{"issue":"4","key":"10.1016\/j.metabol.2026.156621_bb0210","first-page":"883","article-title":"Cloning and chromosomal characterization of the 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase-3 gene (PFKFB3, iPFK2)","volume":"23","author":"Mahlknecht","year":"2003","journal-title":"Int J Oncol"},{"issue":"2","key":"10.1016\/j.metabol.2026.156621_bb0215","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10555-022-10027-5","article-title":"Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux","volume":"41","author":"Jones","year":"2022","journal-title":"Cancer Metastasis Rev"},{"issue":"26","key":"10.1016\/j.metabol.2026.156621_bb0220","doi-asserted-by":"crossref","first-page":"15617","DOI":"10.1016\/S0021-9258(18)55442-9","article-title":"Hepatic 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase. Use of site-directed mutagenesis to evaluate the roles of His-258 and His-392 in catalysis","volume":"265","author":"Tauler","year":"1990","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.metabol.2026.156621_bb0225","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1073\/pnas.78.6.3483","article-title":"Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors","volume":"78","author":"Van Schaftingen","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0230","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/j.gastro.2020.03.008","article-title":"CPEB4 increases expression of PFKFB3 to induce glycolysis and activate mouse and human hepatic stellate cells, promoting Liver Fibrosis","volume":"159","author":"Mejias","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2026.156621_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molmet.2018.11.013","article-title":"6-Phosphofructo-2-kinase\/fructose-2,6-biphosphatase 3 and 4: a pair of valves for fine-tuning of glucose metabolism in human cancer","volume":"20","author":"Yi","year":"2019","journal-title":"Mol Metab"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0240","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/oxfordjournals.jbchem.a021719","article-title":"Characterization of a human placental fructose-6-phosphate, 2-kinase\/fructose-2,6-bisphosphatase","volume":"122","author":"Sakakibara","year":"1997","journal-title":"J Biochem"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0245","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0968-0004(00)01699-6","article-title":"PFK-2\/FBPase-2: maker and breaker of the essential biofactor fructose-2, 6-bisphosphate","volume":"26","author":"Okar","year":"2001","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"10.1016\/j.metabol.2026.156621_bb0250","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0003-9861(85)90197-3","article-title":"Isolation and characterization of 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase from bovine liver","volume":"238","author":"Kountz","year":"1985","journal-title":"Arch Biochem Biophys"},{"issue":"17","key":"10.1016\/j.metabol.2026.156621_bb0255","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1016\/S0021-9258(18)81729-X","article-title":"Purification and characterization of rat skeletal muscle fructose-6-phosphate,2-kinase:fructose-2,6-bisphosphatase","volume":"264","author":"Kitamura","year":"1989","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.metabol.2026.156621_bb0260","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0021-9258(19)75838-4","article-title":"The mechanism of activation of heart fructose 6-phosphate,2-kinase:fructose-2,6-bisphosphatase","volume":"262","author":"Kitamura","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2026.156621_bb0265","doi-asserted-by":"crossref","first-page":"P74","DOI":"10.1186\/2049-3002-2-S1-P74","article-title":"The kinase domain of PFKFB4 is required to stimulate the glucose metabolism and growth of H460 xenografts","volume":"2","author":"Clark","year":"2014","journal-title":"Cancer & Metabolism"},{"issue":"11","key":"10.1016\/j.metabol.2026.156621_bb0270","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1271\/bbb.61.1949","article-title":"Human placental fructose-6-phosphate,2-kinase\/fructose-2,6-bisphosphatase: its isozymic form, expression and characterization","volume":"61","author":"Sakakibara","year":"1997","journal-title":"Biosci Biotechnol Biochem"},{"issue":"2","key":"10.1016\/j.metabol.2026.156621_bb0275","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.molmed.2024.09.005","article-title":"The role of glucose-6-phosphatase activity in glucose homeostasis and its potential for diabetes therapy","volume":"31","author":"Tan","year":"2025","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.metabol.2026.156621_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155142","article-title":"Insulin: the master regulator of glucose metabolism","volume":"129","author":"Norton","year":"2022","journal-title":"Metabolism-Clinical and Experimental"},{"key":"10.1016\/j.metabol.2026.156621_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107995","article-title":"Reprogrammed glucose metabolism in vascular smooth muscle cells and its implications for vascular diseases","volume":"221","author":"Ma","year":"2025","journal-title":"Pharmacol Res"},{"issue":"12","key":"10.1016\/j.metabol.2026.156621_bb0290","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.tem.2024.05.006","article-title":"Increased hepatic gluconeogenesis and type 2 diabetes mellitus","volume":"35","author":"Barroso","year":"2024","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.metabol.2026.156621_bb0295","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a040535","article-title":"Glycolysis","volume":"13","author":"Chandel","year":"2021","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"10.1016\/j.metabol.2026.156621_bb0300","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.tibs.2025.11.002","article-title":"Structural transport and inhibition mechanism of the mitochondrial pyruvate carrier","volume":"51","author":"Lacabanne","year":"2026","journal-title":"Trends Biochem Sci"},{"issue":"12","key":"10.1016\/j.metabol.2026.156621_bb0305","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1038\/s41593-023-01476-4","article-title":"Aerobic glycolysis is the predominant means of glucose metabolism in neuronal somata, which protects against oxidative damage","volume":"26","author":"Wei","year":"2023","journal-title":"Nat Neurosci"},{"issue":"12","key":"10.1016\/j.metabol.2026.156621_bb0310","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.tcb.2023.03.013","article-title":"The Warburg effect: a signature of mitochondrial overload","volume":"33","author":"Wang","year":"2023","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.metabol.2026.156621_bb0315","article-title":"Natural products target glycolysis in liver disease","volume":"14","author":"Li","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.metabol.2026.156621_bb0320","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-nutr-061121-091507","article-title":"Gluconeogenesis flux in metabolic disease","volume":"43","author":"Shah","year":"2023","journal-title":"Annu Rev Nutr"},{"issue":"2","key":"10.1016\/j.metabol.2026.156621_bb0325","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41401-021-00647-y","article-title":"The glycolytic process in endothelial cells and its implications","volume":"43","author":"Susan","year":"2022","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"10.1016\/j.metabol.2026.156621_bb0330","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2024.5429","article-title":"Advances in the understanding of the role and mechanism of action of PFKFB3-mediated glycolysis in liver fibrosis (review)","volume":"54","author":"Liu","year":"2024","journal-title":"Int J Mol Med"},{"issue":"8","key":"10.1016\/j.metabol.2026.156621_bb0335","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/s42255-023-00863-2","article-title":"The pentose phosphate pathway in health and disease","volume":"5","author":"Teslaa","year":"2023","journal-title":"Nat Metab"},{"issue":"23","key":"10.1016\/j.metabol.2026.156621_bb0340","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202402070R","article-title":"PFKFB3 protein in adipose tissue contributes to whole body glucose homeostasis","volume":"38","author":"Griesel","year":"2024","journal-title":"FASEB J"},{"issue":"10","key":"10.1016\/j.metabol.2026.156621_bb0345","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1084\/jem.20130252","article-title":"Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells","volume":"210","author":"Yang","year":"2013","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.metabol.2026.156621_bb0350","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cell.2013.06.037","article-title":"Role of PFKFB3-driven glycolysis in vessel sprouting","volume":"154","author":"De Bock","year":"2013","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.metabol.2026.156621_bb0355","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/ATVBAHA.113.303041","article-title":"Endothelial PFKFB3 plays a critical role in angiogenesis","volume":"34","author":"Xu","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.metabol.2026.156621_bb0360","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1016\/j.apsb.2023.09.012","article-title":"Macrophage LMO7 deficiency facilitates inflammatory injury via metabolic-epigenetic reprogramming","volume":"13","author":"Duan","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.metabol.2026.156621_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2026.116179","article-title":"PFKFB3-involved glycolytic metabolism supports sepsis-induced neutrophil extracellular trap formation","volume":"171","author":"Yin","year":"2026","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0370","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1186\/s12967-024-05753-z","article-title":"GLP-1R activation attenuates the progression of pulmonary fibrosis via disrupting NLRP3 inflammasome\/PFKFB3-driven glycolysis interaction and histone lactylation","volume":"22","author":"Liu","year":"2024","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.metabol.2026.156621_bb0375","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.kint.2024.04.016","article-title":"The glycolytic enzyme PFKFB3 drives kidney fibrosis through promoting histone lactylation-mediated NF-\u03baB family activation","volume":"106","author":"Wang","year":"2024","journal-title":"Kidney Int"},{"issue":"36","key":"10.1016\/j.metabol.2026.156621_bb0380","doi-asserted-by":"crossref","first-page":"24223","DOI":"10.1074\/jbc.M109.016816","article-title":"Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases","volume":"284","author":"Yalcin","year":"2009","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.metabol.2026.156621_bb0385","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.292","article-title":"6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27","volume":"5","author":"Yalcin","year":"2014","journal-title":"Cell Death Dis"},{"issue":"8","key":"10.1016\/j.metabol.2026.156621_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116071","article-title":"PFKFB3 activates CAD to enhance de novo pyrimidine synthesis for cell growth","volume":"44","author":"Da","year":"2025","journal-title":"Cell Rep"},{"issue":"12","key":"10.1016\/j.metabol.2026.156621_bb0395","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/gcc.20914","article-title":"LOH on 10p14-p15 targets the PFKFB3 gene locus in human glioblastomas","volume":"50","author":"Fleischer","year":"2011","journal-title":"Genes Chromosom Cancer"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0405","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbrc.2005.02.193","article-title":"Targeted disruption of inducible 6-phosphofructo-2-kinase results in embryonic lethality","volume":"331","author":"Chesney","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.metabol.2026.156621_bb0410","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0169-328X(01)00014-6","article-title":"Splice isoforms of ubiquitous 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase in human brain","volume":"87","author":"Kessler","year":"2001","journal-title":"Mol Brain Res"},{"issue":"6","key":"10.1016\/j.metabol.2026.156621_bb0415","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.96.6.3047","article-title":"An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect","volume":"96","author":"Chesney","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"10.1016\/j.metabol.2026.156621_bb0420","doi-asserted-by":"crossref","first-page":"19247","DOI":"10.1074\/jbc.M110.190298","article-title":"Cooperation of adenosine with macrophage Toll-4 receptor agonists leads to increased glycolytic flux through the enhanced expression of PFKFB3 gene","volume":"286","author":"Ruiz-Garc\u00eda","year":"2011","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.metabol.2026.156621_bb0425","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1042\/BJ20121886","article-title":"PFKFB3 activation in cancer cells by the p38\/MK2 pathway in response to stress stimuli","volume":"452","author":"Novellasdemunt","year":"2013","journal-title":"Biochem J"},{"issue":"34","key":"10.1016\/j.metabol.2026.156621_bb0430","doi-asserted-by":"crossref","first-page":"30778","DOI":"10.1074\/jbc.M205213200","article-title":"The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase","volume":"277","author":"Marsin","year":"2002","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.metabol.2026.156621_bb0435","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/BJ20111418","article-title":"Progestins activate 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase 3 (PFKFB3) in breast cancer cells","volume":"442","author":"Novellasdemunt","year":"2012","journal-title":"Biochem J"},{"issue":"13","key":"10.1016\/j.metabol.2026.156621_bb0440","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1074\/jbc.M113.529990","article-title":"Estradiol stimulates glucose metabolism via 6-phosphofructo-2-kinase (PFKFB3)","volume":"289","author":"Imbert-Fernandez","year":"2014","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.metabol.2026.156621_bb0445","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1271\/bbb.62.2039","article-title":"A common phosphorylation site for cyclic AMP-dependent protein kinase and protein kinase C in human placental 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase","volume":"62","author":"Okamura","year":"1998","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.metabol.2026.156621_bb0450","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jmb.2013.11.021","article-title":"PFKFB3 regulates oxidative stress homeostasis via its S-glutathionylation in cancer","volume":"426","author":"Seo","year":"2014","journal-title":"J Mol Biol"},{"issue":"51","key":"10.1016\/j.metabol.2026.156621_bb0455","doi-asserted-by":"crossref","first-page":"53562","DOI":"10.1074\/jbc.M406096200","article-title":"6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia","volume":"279","author":"Obach","year":"2004","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.metabol.2026.156621_bb0460","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/iub.2232","article-title":"Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex","volume":"72","author":"Wang","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.metabol.2026.156621_bb0465","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1158\/0008-5472.999.65.3","article-title":"Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death","volume":"65","author":"Blum","year":"2005","journal-title":"Cancer Res"},{"issue":"48","key":"10.1016\/j.metabol.2026.156621_bb0470","doi-asserted-by":"crossref","first-page":"41600","DOI":"10.1074\/jbc.M111.240812","article-title":"Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer","volume":"286","author":"Zawacka-Pankau","year":"2011","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.metabol.2026.156621_bb0475","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41401-025-01651-2","article-title":"Kr\u00fcppel-like factor 15 ameliorates alcohol-induced liver injury in mice via regulation of the PFKFB3\/AKT axis","volume":"47","author":"Chen","year":"2026","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.metabol.2026.156621_bb0480","article-title":"PFKFB3 control of Cancer growth by responding to circadian clock outputs","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2026.156621_bb0485","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.canlet.2021.07.025","article-title":"Fascin promotes lung cancer growth and metastasis by enhancing glycolysis and PFKFB3 expression","volume":"518","author":"Lin","year":"2021","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.metabol.2026.156621_bb0490","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.7150\/thno.98660","article-title":"OTUB2 contributes to vascular calcification in chronic kidney disease via the YAP-mediated transcription of PFKFB3","volume":"15","author":"Li","year":"2025","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.metabol.2026.156621_bb0495","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/ncb1881","article-title":"The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC\/C-Cdh1","volume":"11","author":"Herrero-Mendez","year":"2009","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.metabol.2026.156621_bb0500","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1073\/pnas.1102247108","article-title":"Two ubiquitin ligases, APC\/C-Cdh1 and SKP1-CUL1-F (SCF)-beta-TrCP, sequentially regulate glycolysis during the cell cycle","volume":"108","author":"Tudzarova","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"50","key":"10.1016\/j.metabol.2026.156621_bb0505","doi-asserted-by":"crossref","first-page":"36020","DOI":"10.1074\/jbc.M113.510289","article-title":"Increased concentrations of fructose 2,6-bisphosphate contribute to the Warburg effect in phosphatase and tensin homolog (PTEN)-deficient cells","volume":"288","author":"Cordero-Espinoza","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2026.156621_bb0510","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41418-025-01467-x","article-title":"Metabolic reprogramming in astrocytes prevents neuronal death through a UCHL1\/PFKFB3\/H4K8la positive feedback loop","volume":"32","author":"Xiong","year":"2025","journal-title":"Cell Death Differ"},{"issue":"Suppl 1(Suppl 1)","key":"10.1016\/j.metabol.2026.156621_bb0515","first-page":"S67","article-title":"Diagnosis and classification of diabetes mellitus","volume":"36","author":"Assoc AD","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2026.156621_bb0520","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0140-6736(23)00223-4","article-title":"Type 1 diabetes","volume":"401","author":"Quattrin","year":"2023","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.metabol.2026.156621_bb0525","doi-asserted-by":"crossref","DOI":"10.3390\/biom15060770","article-title":"Targeting CD4+ T cell glucose metabolism: a novel immunotherapeutic approach for type 1 diabetes","volume":"15","author":"Niu","year":"2025","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.metabol.2026.156621_bb0530","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.drudis.2021.11.001","article-title":"Obesity and insulin resistance: pathophysiology and treatment","volume":"27","author":"Tong","year":"2022","journal-title":"Drug Discov Today"},{"issue":"7","key":"10.1016\/j.metabol.2026.156621_bb0535","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100381RR","article-title":"PFKFB3-dependent glucose metabolism regulates 3T3-L1 adipocyte development","volume":"35","author":"Griesel","year":"2021","journal-title":"FASEB J"},{"issue":"25","key":"10.1016\/j.metabol.2026.156621_bb0540","doi-asserted-by":"crossref","first-page":"21492","DOI":"10.1074\/jbc.M112.370379","article-title":"Targeted overexpression of inducible 6-phosphofructo-2-kinase in adipose tissue increases fat deposition but protects against diet-induced insulin resistance and inflammatory responses","volume":"287","author":"Huo","year":"2012","journal-title":"J Biol Chem"},{"issue":"31","key":"10.1016\/j.metabol.2026.156621_bb0545","doi-asserted-by":"crossref","first-page":"23711","DOI":"10.1074\/jbc.M110.123174","article-title":"Involvement of inducible 6-phosphofructo-2-kinase in the anti-diabetic effect of peroxisome proliferator-activated receptor gamma activation in mice","volume":"285","author":"Guo","year":"2010","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.metabol.2026.156621_bb0550","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41374-020-00523-z","article-title":"Adipose tissue inflammation and systemic insulin resistance in mice with diet-induced obesity is possibly associated with disruption of PFKFB3 in hematopoietic cells","volume":"101","author":"Zhu","year":"2021","journal-title":"Lab Investig"},{"issue":"3","key":"10.1016\/j.metabol.2026.156621_bb0555","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/JOE-20-0524","article-title":"Disruption of endothelial Pfkfb3 ameliorates diet-induced murine insulin resistance","volume":"250","author":"Yang","year":"2021","journal-title":"J Endocrinol"},{"issue":"8","key":"10.1016\/j.metabol.2026.156621_bb0560","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00125-015-3584-x","article-title":"Type 2 diabetes alters metabolic and transcriptional signatures of glucose and amino acid metabolism during exercise and recovery","volume":"58","author":"Hansen","year":"2015","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0565","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13148-024-01675-1","article-title":"DNA methylation signatures of youth-onset type 2 diabetes and exposure to maternal diabetes","volume":"16","author":"Salama","year":"2024","journal-title":"Clin Epigenetics"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0570","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13148-020-00896-4","article-title":"The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus","volume":"12","author":"Ahmed","year":"2020","journal-title":"Clin Epigenetics"},{"issue":"6","key":"10.1016\/j.metabol.2026.156621_bb0575","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ajpath.2011.02.036","article-title":"\u03b2-Cell loss and \u03b2-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition","volume":"178","author":"Jurgens","year":"2011","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.metabol.2026.156621_bb0580","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/EJE-17-0724","article-title":"MECHANISMS IN ENDOCRINOLOGY: diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review","volume":"178","author":"Levelt","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.metabol.2026.156621_bb0585","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1007\/s11010-023-04915-9","article-title":"Identification of key genes of diabetic cardiomyopathy in hiPSCs-CMs based on bioinformatics analysis","volume":"479","author":"An","year":"2024","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"10.1016\/j.metabol.2026.156621_bb0590","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s00125-021-05405-7","article-title":"Diabetes induces dysregulation of microRNAs associated with survival, proliferation and self-renewal in cardiac progenitor cells","volume":"64","author":"Purvis","year":"2021","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.metabol.2026.156621_bb0595","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/cvr\/cvac049","article-title":"Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy","volume":"119","author":"Phang","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"22","key":"10.1016\/j.metabol.2026.156621_bb0600","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/CIRCULATIONAHA.110.938217","article-title":"Endothelial cell-derived Endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition","volume":"121","author":"Widyantoro","year":"2010","journal-title":"Circulation"},{"issue":"10225","key":"10.1016\/j.metabol.2026.156621_bb0605","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"issue":"46","key":"10.1016\/j.metabol.2026.156621_bb0610","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035985","article-title":"Multiple-microarray analysis for identification of key genes involved in diabetic nephropathy","volume":"102","author":"Bi","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.metabol.2026.156621_bb0615","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.324","article-title":"IL-22-mediated renal metabolic reprogramming via PFKFB3 to treat kidney injury","volume":"11","author":"Chen","year":"2021","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.metabol.2026.156621_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102201","article-title":"Ferroptosis: mechanisms and role in diabetes mellitus and its complications","volume":"94","author":"Liu","year":"2024","journal-title":"Ageing Res Rev"},{"issue":"8","key":"10.1016\/j.metabol.2026.156621_bb0625","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.18240\/ijo.2024.08.04","article-title":"Key genes and regulatory networks for diabetic retinopathy based on hypoxia-related genes: a bioinformatics analysis","volume":"17","author":"Yu","year":"2024","journal-title":"Int J Ophthalmol"},{"issue":"8","key":"10.1016\/j.metabol.2026.156621_bb0630","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1681\/ASN.0000000000000156","article-title":"PCK1 protects against Mitoribosomal defects in diabetic nephropathy in mouse models","volume":"34","author":"Hasegawa","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.metabol.2026.156621_bb0635","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-017-0913-0","article-title":"Animal models of diabetic retinopathy","volume":"17","author":"Olivares","year":"2017","journal-title":"Curr Diab Rep"},{"issue":"1","key":"10.1016\/j.metabol.2026.156621_bb0640","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1535-7163.MCT-07-0482","article-title":"Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth","volume":"7","author":"Clem","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"10.1016\/j.metabol.2026.156621_bb0645","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1158\/1535-7163.MCT-13-0097","article-title":"Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer","volume":"12","author":"Clem","year":"2013","journal-title":"Mol Cancer Ther"},{"issue":"18","key":"10.1016\/j.metabol.2026.156621_bb0650","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1002\/1873-3468.13878","article-title":"Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatase-3 (PFKFB3)","volume":"594","author":"Emini Veseli","year":"2020","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.metabol.2026.156621_bb0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229395","article-title":"3PO inhibits inflammatory NF\u03baB and stress-activated kinase signaling in primary human endothelial cells independently of its target PFKFB3","volume":"15","author":"Wik","year":"2020","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.metabol.2026.156621_bb0660","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1021\/acs.jmedchem.5b00352","article-title":"Structure-based Design of Potent and Selective Inhibitors of the metabolic kinase PFKFB3","volume":"58","author":"Boyd","year":"2015","journal-title":"J Med Chem"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526001319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526001319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:55:03Z","timestamp":1793944503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049526001319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":131,"alternative-id":["S0026049526001319"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156621","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"6-phosphofructo-2-kinase\/fructose-2,6-biphosphatase 3: A potential target in the development of diabetes and its complications","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156621"}}